发明名称 |
Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one |
摘要 |
Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one. |
申请公布号 |
US9359364(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US201414254023 |
申请日期 |
2014.04.16 |
申请人 |
Signal Pharmaceuticals, LLC |
发明人 |
Menon Anil;Parikh Darshan K.;Visky Dora;Kreilein Matthew Michael;Boersen Nathan;Lee Thomas;Li Ying;Xu Jean;Liang Xiaozhang;Leong William Wei-Hwa;Cohen Benjamin |
分类号 |
C07D487/04;A61K31/4985;C07D471/04;A61K9/20;A61K9/48 |
主分类号 |
C07D487/04 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A crystal form of Compound 1, or a tautomer thereof:which has an X-ray powder diffraction pattern comprising peaks at 9.8±0.2, 12.0±0.2 and 17.9±0.2° 2θ. |
地址 |
San Diego CA US |